LineaGen Inc-Medical Equipment-Deals and Alliances Profile

LineaGen Inc-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME35680D
  • |
  • Pages: 21
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

LineaGen Inc (LineaGen), formerly GenData Research Corporation is a healthcare services provider that includes diagnostic service. The company provides diagnostic evaluation services for complex diseases. Its offers testing services such as FirstStepDx PLUS chromosomal micro array which detect deletions and duplication in genomes, and NextStepDx PLUS a genetic sequencing test to detect smaller changes in genome. LineaGen also offers online screening tool, M-CHAT, to assist physicians and parents to assess and evaluate autism in children. It provides scientific programs such as multiple sclerosis, autism spectrum disorder and chronic obstructive pulmonary disease. The company offers M chat online screening tool for physicians and parents to assess the condition of the patient. LineaGen is headquartered in Salt Lake City, Utah, the US.

LineaGen Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

LineaGen Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016 5

LineaGen Inc, Medical Equipment Deals By Type, 2010 to YTD 2016 6

LineaGen Inc, Medical Equipment, Deals By Region, 2010 to YTD 2016 7

LineaGen Inc, Medical Equipment, Deals By Market, 2010 to YTD 2016 8

LineaGen Inc, Medical Equipment, Deals Summary, 2010 to YTD 2016 9

LineaGen Inc, Medical Equipment, Deal Details 10

Venture Financing 10

LineaGen Raises US$15 Million In Series B Financing 10

Lineagen Secures Additional US$5 Million In Series A Financing Round 12

LineaGen Secures US$1.1 Million In Financing Round 14

Partnerships 15

Tute Genomics Enters into Agreement with LineaGen for Next-Generation Sequencing-Based Diagnostic Test 15

Lineagen Enters Into Co-Development Agreement With Fast Forward 16

LineaGen Inc-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Product News 20

Jan 12, 2016: Lineagen Announces Identification of New Genetic Region Associated with Seizures in Wolf-Hirschhorn Syndrome 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21

List of Figures

LineaGen Inc, Medical Equipment, Deals by Type, 2010 to YTD 2016 1

LineaGen Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016 1

LineaGen Inc, Medical Equipment, Deals By Region, 2010 to YTD 2016 1

LineaGen Inc, Medical Equipment, Deals By Market, 2010 to YTD 2016 1

LineaGen Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016 5

LineaGen Inc, Medical Equipment, Deals by Type, 2010 to YTD 2016 6

LineaGen Inc, Medical Equipment, Deals By Region, 2010 to YTD 2016 7

LineaGen Inc, Medical Equipment, Deals by Market, 2010 to YTD 2016 8

List of Tables

LineaGen Inc, Medical Equipment, Key Facts 1

LineaGen Inc, Medical Equipment, Deals Summary, 2010 to YTD 2016 1

LineaGen Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016 5

LineaGen Inc, Medical Equipment Deals By Type, 2010 to YTD 2016 6

LineaGen Inc, Medical Equipment, Deals By Region, 2010 to YTD 2016 7

LineaGen Inc, Deals By Market, 2010 to YTD 2016 8

LineaGen Inc, Medical Equipment, Deals Summary, 2010 to YTD 2016 9

LineaGen Raises US$15 Million In Series B Financing 10

Lineagen Secures Additional US$5 Million In Series A Financing Round 12

LineaGen Secures US$1.1 Million In Financing Round 14

Tute Genomics Enters into Agreement with LineaGen for Next-Generation Sequencing-Based Diagnostic Test 15

Lineagen Enters Into Co-Development Agreement With Fast Forward 16

LineaGen Inc, Key Competitors 17

LineaGen Inc, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

LineaGen Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17845
Site License
USD 500 INR 35690
Corporate User License
USD 750 INR 53535

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com